Loading
journalsJournal
Annals of surgical oncology
Annals of Surgical Oncology is the main journal of the Society of Surgical Oncology and the leading venue for surgical cancer research, read by surgical oncologists worldwide.
Also called: Annals of Surgical OncologyAnn Surg Oncol
Overview
Annals of Surgical Oncology was launched in 1994 and has been published from New York by Springer since 2005; Crossref records the publisher as Springer - Society of Surgical Oncology, reflecting its role as the society's journal. As its title indicates, it is devoted to surgical oncology, the surgical management of cancer, and it is the venue for the society's clinical research and meeting content. The NLM record lists it as a United States serial that is indexed in MEDLINE; it is not listed in DOAJ.
Publisher
Springer · Society of Surgical Oncology
Scope
surgical oncology
Founded
1994
ISSN
1068-9265
observational202443 citations
Efficacy and Safety of the Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma: Results from an Open-Label, Single-Arm, Multicenter Phase 3 Study
One technology page on OnCo cites this paper by its DOI; this record gives the citation a page of its own so a reader can follow it without leaving OnCo. Read the abstract above alongside the citing page listed under Related; the record was created automatically from the Europe PMC entry and its figures have not been checked by hand.
real world202038 citations
Re-resection in Incidental Gallbladder Cancer: Survival and the Incidence of Residual Disease
A whole-country picture of the gap between guideline and practice: three quarters of eligible patients never reached the second operation. The survival difference is confounded by selection but the residual disease rate is not.
review2018changed practice609 citations
8th Edition of the AJCC Cancer Staging Manual: Pancreas and Hepatobiliary Cancers
The staging change UK pathology reports now carry. Validation against the US National Cancer Database (Giannis 2021) found the eighth edition no better than the seventh at predicting survival overall.
observational201564 citations
Surgical Strategy for T2 Gallbladder Cancer According to Tumor Location
One of the series that raised the question of sparing the liver resection in T2a disease; only 33 peritoneal-side tumours, so it poses the question rather than settles it.
observational2009changed practice141 citations
Prospective multi-institutional study of adjuvant radiotherapy after resection of borderline and malignant phyllodes tumours
Adjuvant radiotherapy is considered after breast conservation for borderline and malignant phyllodes tumours; it does not address the risk of distant spread.
Isabel T. Rubio
Past-President
Breast surgical oncologyBreast cancerOncoplastic surgery
Breast surgeon and ESSO Past-President who heads breast surgical oncology at Clínica Universidad de Navarra in Madrid.
Katsuhiko Uesaka
President of Shizuoka Cancer Center
Cancer centre leadershipMultidisciplinary cancer careCancer genomic medicine
Physician who has led Shizuoka Cancer Center, one of Japan's three largest cancer centres by patient volume, since April 2023.
Kenneth K. Tanabe
President
Surgical oncologyHepatobiliary cancerMelanoma
Massachusetts General Hospital surgical oncologist and 2026-2027 President of the Society of Surgical Oncology, with expertise in liver cancer and melanoma.
Michal Mekel
Director General of Rambam Health Care Campus
Endocrine surgeryHospital managementSurgical oncology
Endocrine surgeon who leads Rambam Health Care Campus, the largest hospital in northern Israel, after nearly three decades at the institution.
Rebecca Auer
Executive Vice-President, Research and Innovation, The Ottawa Hospital / Ottawa Hospital Research Institute
Surgical oncologyPerioperative cancer immunologyOncolytic virus therapy
Cancer surgeon and scientist who leads research and innovation at The Ottawa Hospital and its research institute.
Takashi Kamei
Hospital Director, Tohoku University Hospital
Hospital leadershipAcademic medicineRegional cancer care
Director of Tohoku University Hospital, the leading university hospital and cancer genomic medicine hub for the Tohoku region of Japan.
observationalAnnals of surgical oncology 202443 citations
Efficacy and Safety of the Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma: Results from an Open-Label, Single-Arm, Multicenter Phase 3 Study
One technology page on OnCo cites this paper by its DOI; this record gives the citation a page of its own so a reader can follow it without leaving OnCo. Read the abstract above alongside the citing page listed under Related; the record was created automatically from the Europe PMC entry and its figures have not been checked by hand.
real worldAnnals of Surgical Oncology 202038 citations
Re-resection in Incidental Gallbladder Cancer: Survival and the Incidence of Residual Disease
A whole-country picture of the gap between guideline and practice: three quarters of eligible patients never reached the second operation. The survival difference is confounded by selection but the residual disease rate is not.
reviewAnnals of Surgical Oncology 2018changed practice609 citations
8th Edition of the AJCC Cancer Staging Manual: Pancreas and Hepatobiliary Cancers
The staging change UK pathology reports now carry. Validation against the US National Cancer Database (Giannis 2021) found the eighth edition no better than the seventh at predicting survival overall.
observationalAnnals of Surgical Oncology 201564 citations
Surgical Strategy for T2 Gallbladder Cancer According to Tumor Location
One of the series that raised the question of sparing the liver resection in T2a disease; only 33 peritoneal-side tumours, so it poses the question rather than settles it.
observationalAnnals of surgical oncology 2009changed practice141 citations
Prospective multi-institutional study of adjuvant radiotherapy after resection of borderline and malignant phyllodes tumours
Adjuvant radiotherapy is considered after breast conservation for borderline and malignant phyllodes tumours; it does not address the risk of distant spread.
Similar pages
- JournalSurgical oncology
Shares Michal Mekel, PubMed & Europe PMC.
- JournalEuropean journal of surgical oncology
Shares Isabel T. Rubio, PubMed & Europe PMC.
- TermT2a versus T2b gallbladder cancer (peritoneal side versus hepatic side)
Shares Surgical Strategy for T2 Gallbladder Cancer According to Tumor Location, 8th Edition of the AJCC Cancer Staging Manual: Pancreas and Hepatobiliary Cancers.
- InstitutionEuropean Society of Surgical Oncology
- TermRadical (extended) cholecystectomy
Shares Surgical Strategy for T2 Gallbladder Cancer According to Tumor Location, Re-resection in Incidental Gallbladder Cancer: Survival and the Incidence of Residual Disease.
fronts
institutions
collections
people
key papers
8th Edition of the AJCC Cancer Staging Manual: Pancreas and Hepatobiliary CancersEfficacy and Safety of the Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma: Results from an Open-Label, Single-Arm, Multicenter Phase 3 StudyProspective multi-institutional study of adjuvant radiotherapy after resection of borderline and malignant phyllodes tumoursRe-resection in Incidental Gallbladder Cancer: Survival and the Incidence of Residual DiseaseSurgical Strategy for T2 Gallbladder Cancer According to Tumor Location